Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S I Provatorov

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Kardiologiia|April 30, 2020
[The Incidence and Possible Predictors of Coronary Restenosis]A Yu Filatova, I V Romasov, A V Potekhina, et al.
Terapevticheskii Arkhiv|October 14, 2016
[Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis]O I Afanasievа, E A Pylaeva, E A Klesareva, et al.
Vestnik Rentgenologii I Radiologii|March 18, 2015
[Endovascular treatment for chronic coronary occlusions in patients with coronary heart disease]R O Shirokov, A N Samko, B I Milen'kin, et al.
Bulletin of Experimental Biology and Medicine|July 20, 2005
Low daily dose of antioxidant probucol decreases incidence and severity of restenosis after transluminal coronary balloon angioplastyA I Kaminnyi, V Z Lankin, A N Samko, et al.
Kardiologiia|August 2, 2017
[Subpopulation Composition of CD4+ T-lymphocytes as Factor Contributing to the Progression of Atherosclerosis of Carotid Arteries]A Yu Filatova, E A Pylaeva, A V Potekhina, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting]A M Shchinova, G V Shlevkova, A Y Filatova, et al.
Kardiologiia|November 6, 2020
[The prognostic value of high-sensitivity C-reactive protein blood level after coronary stenting for the development of stent restenosis]A Yu Filatova, G V Shlevkova, A V Potekhina, et al.
Terapevticheskii Arkhiv|March 15, 2021
[Analysis of the causes of repeat stenosis of the coronary arteries after elective stenting in patients with stable angina pectoris]A Y Filatova, A K Osokina, A V Potekhina, et al.
Terapevticheskii Arkhiv|March 9, 2011
[Effect of the anti-inflammatory peptide preparation ingramon on the blood levels of acute-phase proteins and chemokines in patients after coronary stenting]A V Potekhina, S I Provatorov, T I Aref'eva, et al.
Bulletin of Experimental Biology and Medicine|January 11, 2019
Low Blood Content of IL-10-Producing CD4<sup>+</sup> T Cells as a Risk Factor for Progression of Coronary AtherosclerosisA Yu Filatova, E A Pylaeva, A V Potekhina, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Kardiologiia|April 30, 2020
[The Incidence and Possible Predictors of Coronary Restenosis]A Yu Filatova, I V Romasov, A V Potekhina, et al.
Terapevticheskii Arkhiv|October 14, 2016
[Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis]O I Afanasievа, E A Pylaeva, E A Klesareva, et al.
Vestnik Rentgenologii I Radiologii|March 18, 2015
[Endovascular treatment for chronic coronary occlusions in patients with coronary heart disease]R O Shirokov, A N Samko, B I Milen'kin, et al.
Bulletin of Experimental Biology and Medicine|July 20, 2005
Low daily dose of antioxidant probucol decreases incidence and severity of restenosis after transluminal coronary balloon angioplastyA I Kaminnyi, V Z Lankin, A N Samko, et al.
Kardiologiia|August 2, 2017
[Subpopulation Composition of CD4+ T-lymphocytes as Factor Contributing to the Progression of Atherosclerosis of Carotid Arteries]A Yu Filatova, E A Pylaeva, A V Potekhina, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting]A M Shchinova, G V Shlevkova, A Y Filatova, et al.
Kardiologiia|November 6, 2020
[The prognostic value of high-sensitivity C-reactive protein blood level after coronary stenting for the development of stent restenosis]A Yu Filatova, G V Shlevkova, A V Potekhina, et al.
Terapevticheskii Arkhiv|March 15, 2021
[Analysis of the causes of repeat stenosis of the coronary arteries after elective stenting in patients with stable angina pectoris]A Y Filatova, A K Osokina, A V Potekhina, et al.
Terapevticheskii Arkhiv|March 9, 2011
[Effect of the anti-inflammatory peptide preparation ingramon on the blood levels of acute-phase proteins and chemokines in patients after coronary stenting]A V Potekhina, S I Provatorov, T I Aref'eva, et al.
Bulletin of Experimental Biology and Medicine|January 11, 2019
Low Blood Content of IL-10-Producing CD4<sup>+</sup> T Cells as a Risk Factor for Progression of Coronary AtherosclerosisA Yu Filatova, E A Pylaeva, A V Potekhina, et al.
Pageof 3